Susan A Greenfield

Increases in a pivotal bioactive peptide in specific brain regions reflect the progression of pathology in Alzheimer’s disease

Abnormal activation of a developmental process driven by a bioactive peptide T14, is posited as a key mechanism in the degeneration of the primarily vulnerable nuclei during the prodromal phase of Alzheimer’s Disease (AD). We use a range of anatomical, biochemical and genetic app...